News from Piramal Imaging A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jul 19, 2017, 13:33 ET Piramal Imaging Applauds Interim Results and Reiterates Support of IDEAS Trial in Mild Cognitive Impairment (MCI) and Atypical Dementia

Trial Led by Alzheimer's Association and American College of Radiology Evaluating Impact of Brain Amyloid PET Imaging on Patient Management and...


Aug 31, 2015, 11:15 ET Piramal Imaging Announces Publication of Phase III Neuraceq™ (florbetaben F18) PET Imaging Data in Alzheimer's & Dementia

Piramal Imaging announced today the publication of results from its pivotal Phase III trial of Neuraceq™ (florbetaben F18 injection), a...


Jun 02, 2015, 08:00 ET Piramal Imaging SA and Ci-Co Healthcare Announce Commercial Approval of Neuraceq™ in Korea

 Piramal Imaging SA and Ci-Co Healthcare today announce that the companies have received marketing authorization by the Ministry of Food and...


Oct 17, 2013, 09:00 ET Piramal Imaging Highlights New Data for Beta-Amyloid Imaging Agent Florbetaben F18 at EANM 2013

 Piramal Imaging announced today that results from four studies evaluating the Company's PET amyloid imaging agent, florbetaben F18*, will...


Aug 19, 2013, 12:31 ET Piramal Imaging Provides Comments in Response to the Centers for Medicare and Medicaid Services (CMS) Proposed Coverage Decision for Beta-Amyloid Positron Emission Tomography (PET)

 Piramal Imaging announced today that the Company has submitted a detailed response to CMS regarding the draft decision to limit Medicare...


Jul 12, 2013, 10:54 ET Piramal Imaging Highlights New Data for Florbetaben F18 at AAIC 2013

Piramal Imaging announced today that results from five studies evaluating the Company's PET amyloid imaging agent (florbetaben F18*) will be...


Jun 06, 2013, 11:13 ET Piramal Imaging Highlights New Data for Florbetaben and Other Investigational Radiopharmaceuticals at SNMMI 2013

Piramal Imaging announced today that results from four studies evaluating the Company's PET amyloid imaging agent (florbetaben F18*) will be...


May 07, 2013, 11:45 ET Piramal Imaging Welcomes Ana M. Catafau, M.D., Ph.D., as VP, Clinical Research and Development, Neurosciences

Piramal Imaging SA, a division of Piramal Enterprises, today announced Ana M. Catafau, M.D., Ph.D., has joined the company as vice president (VP)...